View, the leader in dynamic glass, today announced Thomas C. Leppert has joined its board of directors. A former CEO of multiple large, international companies in the building industry and former mayor of Dallas, Leppert brings deep experience in both … Continued
Selecta Biosciences, Inc., a clinical stage biotechnology company developing a novel class of targeted antigen-specific immune therapies, announced today that it has completed a $38 million Series E equity financing. Proceeds from the financing will be used to advance multiple … Continued
Selecta Biosciences, Inc., a clinical stage biotechnology company developing a novel class of targeted antigen-specific immune therapies using Synthetic Vaccine Particles (SVP), today announced the appointment of Earl (‘Skip’) Sands, MD, as Chief Medical Officer (CMO). As CMO, Dr. Sands … Continued
View, the leader in dynamic glass, today announced it has raised $150 million in equity funding to finance manufacturing expansion and company growth. Participants in this round included new investor NZ Super Fund, existing investors Corning Incorporated (NYSE: GLW), Madrone … Continued
Ask most developers about magnetic sensors and they’ll first think of the Hall Effect. But there’s another approach that has come to market, one that promises increased sensitivity, smaller sensor size, and lower power consumption. Leveraging the quantum effect of … Continued
Mother Nature has always been life’s master architect, working off genetic blueprints that are fine-tuned from one generation to the next. Until now. Scientists increasingly are designing life from scratch, using inexpensive, fast and accurate tools to create and assemble … Continued
View’s Dynamic Glass profiled as an Intelligent Window by Gadget Review. “On the list of everyday objects to get the “smart” treatment, you might not be surprised to find windows as the latest addition – after all, they already look … Continued
Twist Bioscience, a company focused on synthetic DNA, today announced the appointment of Solange Glaize, former corporate controller and chief accounting officer for Agilent Technologies, to the newly created position of chief financial officer. “We are thrilled to welcome Solange … Continued
Selecta Biosciences, Inc., a clinical stage biotechnology company developing a novel class of targeted antigen-specific immune therapies, today announced that it has initiated a Phase 1 clinical study to assess the safety, pharmacodynamic profile, and immunogenicity of pegsiticase, a component … Continued
Emulate, Inc. today announced that it recently formed a research collaboration with Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson (“Janssen”), to deploy Emulate’s Organs-on-Chips platform across certain Janssen programs to better predict the potential human response … Continued